“…Patients were screened as previously described using TaqMan assays (Applied Biosystems/Life Technologies, Carlsbad, CA, USA) for the PITX2 and FOXC1 regions and/or Affymetrix Genome-Wide Human SNP Array 6.0 (Affymetrix, Santa Clara, CA, USA); 19,26 clinical Agilent 105K oligonucleotide array (Agilent Technologies, Santa Clara, CA, USA) and Affymetrix 6.0 array data were used for one patient each (cases 21 and 27, respectively). The following PITX2 probes were used for TaqMan assays: Hs00452261_cn (P1, located in the last exon of PITX2), Hs00958157_cn (P2, PITX2C promoter), Hs01402614_cn (P3, most 5' PITX2 exon, exon 1A), Hs06705585_cn (P3B, located at B50 kb upstream of PITX2), Hs04822300_cn (P4, located 110 366 kb 5' of PITX2), Hs04838001_cn (P5, located 284 481 kb 5' of PITX2), and Hs04811562_cn (P6, located 649 476 upstream of PITX2).…”